Canadian DIN & Molecule SearchMolecules A–ZDrug ShortagesResourcesHealth Canada WeeklyRequest a Quote

CEFTAZIDIME FOR INJECTION BP DIN 02437848

Status: Marketed
Holder: STERIMAX INC
Molecule: CEFTAZIDIME (CEFTAZIDIME PENTAHYDRATE)
Available to quote

Health Canada record

Active ingredient(s)CEFTAZIDIME (CEFTAZIDIME PENTAHYDRATE) 1 G
Dosage formPowder For Solution
RouteIntravenous; Intramuscular
SchedulePRESCRIPTION
ClassHuman
ATCJ01DD02 CEFTAZIDIME
Original market date28-May-2015
Current status date28-May-2015
SourceHealth Canada DPD

Establishment licence of the holder

Sterimax Inc — licence 100925, currently licensed, last inspection rating C (2024-05-13).

No Canadian shortage report is currently matched to this DIN.

Other Canadian products containing CEFTAZIDIME (CEFTAZIDIME PENTAHYDRATE)

DINProductCompanyFormStrengthStatus
02437856CEFTAZIDIME FOR INJECTION BPSTERIMAX INCPowder For SolutionCEFTAZIDIME (CEFTAZIDIME PENTAHYDRATE) 2 GMarketed
02437864CEFTAZIDIME FOR INJECTION BPSTERIMAX INCPowder For SolutionCEFTAZIDIME (CEFTAZIDIME PENTAHYDRATE) 6 GMarketed
02439522CEFTAZIDIME FOR INJECTION, BPSTERIMAX INCPowder For SolutionCEFTAZIDIME (CEFTAZIDIME PENTAHYDRATE) 3 GDormant
02212226FORTAZGLAXOSMITHKLINE INCPowder For SolutionCEFTAZIDIME (CEFTAZIDIME PENTAHYDRATE) 2 GCancelled Post Market
02212218FORTAZGLAXOSMITHKLINE INCPowder For SolutionCEFTAZIDIME (CEFTAZIDIME PENTAHYDRATE) 1 GCancelled Post Market
02212234FORTAZGLAXOSMITHKLINE INCPowder For SolutionCEFTAZIDIME (CEFTAZIDIME PENTAHYDRATE) 6 GCancelled Post Market
00640034FORTAZ INJ 1GM/VIALGLAXO CANADA INCPowder For SolutionCEFTAZIDIME (CEFTAZIDIME PENTAHYDRATE) 1 GCancelled Post Market
00640042FORTAZ INJ 2GM/VIALGLAXO CANADA INCPowder For SolutionCEFTAZIDIME (CEFTAZIDIME PENTAHYDRATE) 2 GCancelled Post Market
00640026FORTAZ INJ 500MG/VIALGLAXO CANADA INCPowder For SolutionCEFTAZIDIME (CEFTAZIDIME PENTAHYDRATE) 500 MGCancelled Post Market
00791679FORTAZ PWS INJ 6GM/VIALGLAXO CANADA INCPowder For SolutionCEFTAZIDIME (CEFTAZIDIME PENTAHYDRATE) 6 GCancelled Post Market

Notices of Compliance

NOCDateSubmissionReason
166512015-02-27Abbreviated New Drug Submission (ANDS)
Request a quote for CEFTAZIDIME FOR INJECTION BP

How to read a Canadian DIN record